Credit Suisse’s OrthoPediatrics KIDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$417K Hold
14,300
﹤0.01% 2713
2023
Q4
$465K Sell
14,300
-1,966
-12% -$57K ﹤0.01% 2764
2023
Q3
$521K Sell
16,266
-1,687
-9% -$65K ﹤0.01% 2668
2023
Q2
$787K Buy
17,953
+3,010
+20% +$139K ﹤0.01% 2545
2023
Q1
$662K Buy
14,943
+2,975
+25% +$131K ﹤0.01% 2576
2022
Q4
$475K Buy
11,968
+1,271
+12% +$53K ﹤0.01% 2817
2022
Q3
$495K Buy
10,697
+704
+7% +$34.5K ﹤0.01% 2783
2022
Q2
$432K Sell
9,993
-174
-2% -$7.96K ﹤0.01% 2933
2022
Q1
$548K Buy
10,167
+694
+7% +$35.5K ﹤0.01% 2915
2021
Q4
$567K Sell
9,473
-1,161
-11% -$72.3K ﹤0.01% 3726
2021
Q3
$697K Buy
10,634
+798
+8% +$51.8K ﹤0.01% 3588
2021
Q2
$622K Buy
9,836
+1,996
+25% +$115K ﹤0.01% 3705
2021
Q1
$382K Sell
7,840
-6,942
-47% -$333K ﹤0.01% 3908
2020
Q4
$610K Buy
14,782
+6,185
+72% +$284K ﹤0.01% 3687
2020
Q3
$395K Buy
8,597
+1,245
+17% +$57.8K ﹤0.01% 3515
2020
Q2
$322K Buy
7,352
+2,144
+41% +$96.4K ﹤0.01% 3544
2020
Q1
$206K Sell
5,208
-826
-14% -$37K ﹤0.01% 3632
2019
Q4
$283K Buy
+6,034
New +$234K ﹤0.01% 3846

Other funds holding KIDS

Credit Suisse's KIDS Position: Q1 2024 in Review

Credit Suisse held its OrthoPediatrics (KIDS) position steady in Q1 2024 at 14,300 shares worth $417K. The position accounts for ﹤0.01% of the portfolio, ranked #2713.

Credit Suisse first reported a position in KIDS in Q4 2019 and has held it in 18 quarters since. The position peaked at $787K in Q2 2023. 121 funds tracked by Wall St. Rank hold KIDS as of Q1 2024.

  • Credit Suisse held 14,300 shares of OrthoPediatrics worth $417K as of Q1 2024.
  • Credit Suisse left its OrthoPediatrics share count unchanged in Q1 2024.
  • OrthoPediatrics made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2713 holding.
  • Credit Suisse first reported a position in OrthoPediatrics in Q4 2019 and has held it in 18 quarters since.
  • Credit Suisse's OrthoPediatrics position peaked at $787K in Q2 2023.
  • 121 funds tracked by Wall St. Rank held OrthoPediatrics as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.